{"id":8658,"date":"2024-03-25T19:06:52","date_gmt":"2024-03-25T18:06:52","guid":{"rendered":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2024\/03\/20240311-Tubulis-Series-B2-Press-Release-Seventure.pdf"},"modified":"2024-03-25T19:06:52","modified_gmt":"2024-03-25T18:06:52","slug":"20240311-tubulis-series-b2-press-release-seventure","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/tubulis-closes-upsized-e128-million-series-b2-to-accelerate-clinical-development-of-solid-tumor-focused-adc-pipeline\/20240311-tubulis-series-b2-press-release-seventure\/","title":{"rendered":"20240311 Tubulis Series B2 Press Release Seventure"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8658","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n